Filing Details
- Accession Number:
- 0001209191-21-055490
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-10 17:14:11
- Reporting Period:
- 2021-05-28
- Accepted Time:
- 2021-09-10 17:14:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1684087 | Caroline Young | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-28 | 15 | $2.93 | 12,398 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-01 | 15 | $2.94 | 12,413 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-02 | 15 | $2.89 | 12,428 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-03 | 15 | $2.81 | 12,443 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-04 | 15 | $2.93 | 12,458 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-07 | 15 | $2.94 | 12,473 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-08 | 15 | $2.99 | 12,488 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-09 | 15 | $3.14 | 12,503 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-10 | 15 | $3.25 | 12,518 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-11 | 15 | $3.18 | 12,533 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-14 | 15 | $3.09 | 12,548 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-15 | 15 | $3.09 | 12,563 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-16 | 15 | $3.09 | 12,578 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-17 | 15 | $3.08 | 12,593 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-18 | 15 | $2.99 | 12,608 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-21 | 15 | $3.14 | 12,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-22 | 15 | $3.05 | 12,638 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-23 | 15 | $3.07 | 12,653 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-24 | 15 | $3.09 | 12,668 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-25 | 15 | $3.09 | 12,683 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-28 | 15 | $3.16 | 12,698 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-29 | 15 | $3.03 | 12,713 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-06-30 | 15 | $2.93 | 12,728 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
